Cargando...
Comparison of futility monitoring guidelines using completed phase III oncology trials
BACKGROUND: Futility (inefficacy) interim monitoring is an important component in the conduct of phase III clinical trials, especially in life threatening diseases. Desirable futility monitoring guidelines allow timely stopping if the new therapy is harmful or if it is unlikely to demonstrate to be...
Gardado en:
| Publicado en: | Clin Trials |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
2016
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5300958/ https://ncbi.nlm.nih.gov/pubmed/27590208 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1740774516666502 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|